Europe's premier partnering event
Save the date for next yearNovember 3–5, 2025 | Vienna, Austria Reagan JarvisCEO, Scientific founder at AnoccaSpeaker
Profile
Reagan Jarvis is the co-founder and CEO of Anocca, a T-cell immunotherapy company based out of Sweden, commencing FIH clinical trials in 2025 with TCR-T cell therapy products in oncology.
A New Zealander, Jarvis obtained his PhD in Biochemistry at University of Otago and performed postdoctoral research at the University of Otago and thereafter the German Cancer Research Center (DKFZ) in Heidelberg. He founded Anocca with Mikael Blomqvist in 2014.
Anocca currently has a pipeline of 40 products. It has 120+ staff, with 36 nationalities and operates the largest cGMP cell therapy manufacturing site in the Nordics.
Agenda Sessions
“Under Attack”: Can cell & gene therapy revolutionise the rules of healthcare?
, 16:00View Session